Organization
University College London, Medical Oncology, London, United Kingdom
1 abstract
Abstract
ABATACEPT AND THE RISK OF MALIGNANCY: A META-ANALYSIS ACROSS DISEASE INDICATIONSOrg: King’s College London, Centre for Rheumatic Disease, London, United Kingdom, King’s College London, London, United Kingdom, University College London, Medical Oncology, London, United Kingdom, King’s College London, Centre for Rheumatic Diseases, London, United Kingdom,